Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Ponce Financial (PDLB) is on the Move, Here's Why the Trend Could be Sustainable
Ponce Financial (PDLB) is on the Move, Here's Why the Trend Could be Sustainable

When it comes to short-term investing or trading, they say "the trend is your friend." And there's no denying that this is the most profitable strategy. But making sure of the sustainability of a

3 Stocks to Watch From the Satellite and Communication Industry
3 Stocks to Watch From the Satellite and Communication Industry
Macroeconomic uncertainty amid tariff troubles, inflation and supply chain dynamics could affect the Zacks Satellite and Communication industry's growth prospects. Moreover, high capital expenditure
Is the Options Market Predicting a Spike in Tyson Foods (TSN) Stock?
Is the Options Market Predicting a Spike in Tyson Foods (TSN) Stock?

Investors in Tyson Foods, Inc. TSN need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $35.00 Call had some of the highest implied

Are Options Traders Betting on a Big Move in Tetra Tech (TTEK) Stock?
Are Options Traders Betting on a Big Move in Tetra Tech (TTEK) Stock?

Investors in Tetra Tech, Inc. TTEK need to pay close attention to the stock based on moves in the options market lately. That is because the June 20, 2025 $70.00 Call had some of the highest implied

M/A-Com (MTSI) Q2 Earnings and Revenues Beat Estimates
M/A-Com (MTSI) Q2 Earnings and Revenues Beat Estimates

M/A-Com (MTSI) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.59 per share a year ago. These figures

Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) came out with a quarterly loss of $1.10 per share versus the Zacks Consensus Estimate of a loss of $1.26. This compares to loss of $1.06 per share a year ago

Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates
Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates

Delcath Systems, Inc. (DCTH) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to loss of $0.43 per share a year ago. These

Lifetime Brands (LCUT) Reports Q1 Loss, Misses Revenue Estimates
Lifetime Brands (LCUT) Reports Q1 Loss, Misses Revenue Estimates

Lifetime Brands (LCUT) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to loss of $0.15 per share a year ago. These figures

Kelly Services (KELYA) Lags Q1 Earnings Estimates
Kelly Services (KELYA) Lags Q1 Earnings Estimates

Kelly Services (KELYA) came out with quarterly earnings of $0.39 per share, missing the Zacks Consensus Estimate of $0.53 per share. This compares to earnings of $0.56 per share a year ago. These

Installed Building Products (IBP) Misses Q1 Earnings Estimates
Installed Building Products (IBP) Misses Q1 Earnings Estimates

Installed Building Products (IBP) came out with quarterly earnings of $2.08 per share, missing the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $2.47 per share a year

Allegro MicroSystems, Inc. (ALGM) Beats Q4 Earnings and Revenue Estimates
Allegro MicroSystems, Inc. (ALGM) Beats Q4 Earnings and Revenue Estimates

Allegro MicroSystems, Inc. (ALGM) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.25 per share a year

Berry Petroleum (BRY) Beats Q1 Earnings Estimates
Berry Petroleum (BRY) Beats Q1 Earnings Estimates

Berry Petroleum (BRY) came out with quarterly earnings of $0.12 per share, beating the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.14 per share a year ago. These

Lear's Q1 Earnings & Revenues Surpass Estimates, Decline Y/Y
Lear's Q1 Earnings & Revenues Surpass Estimates, Decline Y/Y

Lear Corp. LEA reported its first quarter 2025 adjusted earnings per share of $3.12, which beat the Zacks Consensus Estimate of $2.64, thanks to higher-than-expected revenues and profits from the

ConocoPhillips Q1 Earnings Beat Estimates, Revenues Improve Y/Y
ConocoPhillips Q1 Earnings Beat Estimates, Revenues Improve Y/Y

ConocoPhillips COP reported first-quarter 2025 adjusted earnings per share of $2.09, which beat the Zacks Consensus Estimate of $2.06. The bottom line increased from the prior-year level of $2.03

Sonos' Q2 Loss Matches Estimates, Revenues Increase Y/Y
Sonos' Q2 Loss Matches Estimates, Revenues Increase Y/Y

Sonos, Inc. SONO reported second-quarter fiscal 2025 non-GAAP loss per share of 18 cents, meeting the Zacks Consensus Estimate. It incurred a loss of 18 cents in the prior-year quarter as well. On a

4 Stocks With Impressive Shareholder Yield to Safeguard Your Portfolio
4 Stocks With Impressive Shareholder Yield to Safeguard Your Portfolio

In the world of investing, shareholders seek the best returns while managing risk. One key metric that has gained traction among savvy investors is shareholder yield — a comprehensive measure that

Is the Options Market Predicting a Spike in The Cheesecake Factory Stock?
Is the Options Market Predicting a Spike in The Cheesecake Factory Stock?

Investors in The Cheesecake Factory Incorporated CAKE need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 18, 2025 $30 Call had some of the

PENN Entertainment (PENN) Reports Q1 Loss, Misses Revenue Estimates
PENN Entertainment (PENN) Reports Q1 Loss, Misses Revenue Estimates

PENN Entertainment (PENN) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to loss of $0.79 per share a year ago. These figures

Stagwell (STGW) Misses Q1 Earnings and Revenue Estimates
Stagwell (STGW) Misses Q1 Earnings and Revenue Estimates

Stagwell (STGW) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.16 per share a year ago. These figures

Americold Realty Trust Inc. (COLD) Meets Q1 FFO Estimates
Americold Realty Trust Inc. (COLD) Meets Q1 FFO Estimates

Americold Realty Trust Inc. (COLD) came out with quarterly funds from operations (FFO) of $0.34 per share, in line with the Zacks Consensus Estimate. This compares to FFO of $0.37 per share a year

Dave Inc. (DAVE) Beats Q1 Earnings and Revenue Estimates
Dave Inc. (DAVE) Beats Q1 Earnings and Revenue Estimates

Dave Inc. (DAVE) came out with quarterly earnings of $2.48 per share, beating the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $0.62 per share a year ago. These figures

Malibu Boats (MBUU) Beats Q3 Earnings and Revenue Estimates
Malibu Boats (MBUU) Beats Q3 Earnings and Revenue Estimates

Malibu Boats (MBUU) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.67 per share. This compares to earnings of $0.63 per share a year ago. These

BigCommerce (BIGC) Surpasses Q1 Earnings Estimates
BigCommerce (BIGC) Surpasses Q1 Earnings Estimates

BigCommerce (BIGC) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.06 per share a year ago. These

Chipotle Stock Gains 10% Since Q1 Results: Time to Buy, Sell or Hold?
Chipotle Stock Gains 10% Since Q1 Results: Time to Buy, Sell or Hold?

Chipotle Mexican Grill, Inc. CMG shares have climbed 9.6% following the release of its first-quarter 2025 results, reflecting investor confidence in the company's long-term strategy despite

Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock?Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Are Options Traders Betting on a Big Move in Amneal Pharmaceuticals Stock?

Investors in Amneal Pharmaceuticals, Inc. AMRX need to pay close attention to the stock based on moves in the options market lately. That is because the Jun 20, 2025 $2.5 Call had some of the